Hememics Biotechnologies Closes $2M Seed 2 Round
The firm is developing a handheld multiplexed biosensor platform to detect antibodies, antigens, and molecular targets simultaneously.
Foresight Diagnostics Closes $58.8M Series B Round
The Aurora, Colorado-based company plans to accelerate the clinical development and commercialization of its PhasED-seq MRD testing platform.
Epic Sciences Raises $24M, Expands Commercial Infrastructure for Breast Cancer Liquid Biopsy Test
The firm is growing its sales, product marketing, and customer service teams for its multiomic metastatic breast cancer liquid biopsy test, DefineMBC.
Mercy BioAnalytics Raises $41M in Series A Financing
The proceeds will help develop and commercialize its extracellular vesicle-based Mercy Halo platform for lung, ovarian, and other cancer screening tests.
Previse Launches Esophageal Cancer Risk Test, Raises $3M to Support Commercial Expansion
The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.